Keyword: Hatteras Venture Partners
The first close of the targeted $200 million fund tees Hatteras up to make a fresh batch of seed and early-stage biotech investments.
Andrew Witty jumped into biotech venture capital, Aerie poached another exec from Alcon, Roivant tapped Silicon Valley vet to run trial AI company.
The former GSK CEO is taking up a venture partner post at the VC shop, setting him up to offer advice on the positioning of its portfolio companies.
Boston Scientific has led a $23.1 million Series B investment in in heart failure firm NeuroTronik.